These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2164191)

  • 1. Effect of subtype-selective opioid receptor blockers on nitrous oxide antinociception in rats.
    Quock RM; Walczak CK; Henry RJ; Chen DC
    Pharmacol Res; 1990; 22(3):351-7. PubMed ID: 2164191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of "selective" opiate receptor antagonists on the isolated mouse vas deferens.
    Smith CB; Bennett-Kelly L; Woods JH
    Neuropeptides; 1984 Dec; 5(1-3):161-4. PubMed ID: 6099488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
    Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cyclobutylmethyl analog of normorphinone, N-CBM-TAMO: a short-term opioid agonist and long-term Mu-selective irreversible opioid antagonist.
    Xu JY; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1996 Nov; 279(2):539-47. PubMed ID: 8930155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
    Horan P; de Costa BR; Rice KC; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICI 154,129, a delta-opioid receptor antagonist raises seizure threshold in rats.
    Tortella FC; Robles LE; Holaday JW; Cowan A
    Eur J Pharmacol; 1984 Jan; 97(1-2):141-4. PubMed ID: 6321207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etonitazene-induced antinociception in mu1 opioid receptor deficient CXBK mice: evidence for a role for mu2 receptors in supraspinal antinociception.
    Connelly CD; Martinez RP; Schupsky JJ; Porreca F; Raffa RB
    Life Sci; 1994; 54(21):PL369-74. PubMed ID: 7910928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecific inhibition of oxotremorine-induced antinociception by (+)-isomers of opioid antagonists: comparison with opioid receptor agonists.
    Ben-Sreti MM; Sewell RD
    J Pharm Pharmacol; 1982 Aug; 34(8):501-5. PubMed ID: 6126560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for delta-receptor involvement in the post-ictal antinociceptive responses to electroconvulsive shock in rats.
    Belenky GL; Gelinas-Sorell D; Kenner JR; Holaday JW
    Life Sci; 1983; 33 Suppl 1():583-5. PubMed ID: 6319914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD; Bayer BM
    Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Eur J Pharmacol; 1991 Dec; 205(3):247-52. PubMed ID: 1667910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by U-50,488H against beta-chlornaltrexamine antagonism of nitrous oxide antinociception in mice.
    Quock RM; Mueller J
    Brain Res; 1991 May; 549(1):162-4. PubMed ID: 1832578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
    Sakurada S; Zadina JE; Kastin AJ; Katsuyama S; Fujimura T; Murayama K; Yuki M; Ueda H; Sakurada T
    Eur J Pharmacol; 1999 May; 372(1):25-30. PubMed ID: 10374711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of narcotic antagonist drugs upon nitrous oxide analgesia in mice.
    Quock RM; Graczak LM
    Brain Res; 1988 Feb; 440(1):35-41. PubMed ID: 2833991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of central opiate receptor subtypes in the circulatory responses of awake rabbits to graded caval occlusions.
    Evans RG; Ludbrook J; Van Leeuwen AF
    J Physiol; 1989 Dec; 419():15-31. PubMed ID: 2559974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mediation of catecholaminergic pathways in the antinociceptive effect of an extract of Cannabis sativa L.
    Ferri S; Cavicchini E; Romualdi P; Speroni E; Murari G
    Psychopharmacology (Berl); 1986; 89(2):244-7. PubMed ID: 3088644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats.
    Crook TJ; Kitchen I; Hill RG
    Br J Pharmacol; 1992 Oct; 107(2):573-6. PubMed ID: 1330187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.